The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer

Barry J. Laird (Corresponding Author), Donald C. McMillan, Peter Fayers, Kenneth Fearon, Stein Kaasa, Marie T. Fallon, Pål Klepstad

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Introduction. Inflammation has been identified as a hallmark of cancer and may be necessary for tumorgenesis and maintenance of the cancer state. Inflammation-related symptoms are common in those with cancer; however, little is known about the relationship between symptoms and systemic inflammation in cancer. The aim of the present study was to examine the relationship between symptoms and systemic inflammation in a large cohort of patients with advanced cancer. 

Methods. Data from an international cohort of patients with advanced cancer were analyzed. Symptoms and patient-related outcomes were recorded using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core Questionnaire. Systemic inflammation was assessed using C-reactive protein levels. The relationship between these symptoms and systemic inflammation was examined using Spearman rank correlation (ρ) and the Mann-Whitney U test. 

Results. Data were available for 1,466 patients across eight European countries; 1,215 patients (83%) had metastatic disease at study entry. The median survival was 3.8 months (interquartile range [IQR] 1.3-12.2 months). The following were associated with increased levels of inflammation: performance status (p=.179), survival (p=.347), pain (p=.154), anorexia (p=.206), cognitive dysfunction (p=.137), dyspnea (p.150), fatigue (p=.197), physical dysfunction (p=.207), role dysfunction (p=.176), social dysfunction (p=.132), and poor quality of life (p=.178). All were statistically significant at p<.001. 

Conclusion. The results show that the majority of cancer symptoms are associated with inflammation. The strength of the potential relationship between systemic inflammation and common cancer symptoms should be examined further within the context of an anti-inflammatory intervention trial.

Original languageEnglish
Pages (from-to)1050-1055
Number of pages6
JournalOncologist
Volume18
Issue number9
Early online date21 Aug 2013
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Inflammation
Pain
Neoplasms
Quality of Life
Survival
Anorexia
Nonparametric Statistics
Dyspnea
C-Reactive Protein
Fatigue
Anti-Inflammatory Agents
Maintenance

Keywords

  • Cancer
  • Inflammation
  • Symptoms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Laird, B. J., McMillan, D. C., Fayers, P., Fearon, K., Kaasa, S., Fallon, M. T., & Klepstad, P. (2013). The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer. Oncologist, 18(9), 1050-1055. https://doi.org/10.1634/theoncologist.2013-0120

The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer. / Laird, Barry J. (Corresponding Author); McMillan, Donald C.; Fayers, Peter; Fearon, Kenneth; Kaasa, Stein; Fallon, Marie T.; Klepstad, Pål.

In: Oncologist, Vol. 18, No. 9, 09.2013, p. 1050-1055.

Research output: Contribution to journalArticle

Laird, BJ, McMillan, DC, Fayers, P, Fearon, K, Kaasa, S, Fallon, MT & Klepstad, P 2013, 'The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer', Oncologist, vol. 18, no. 9, pp. 1050-1055. https://doi.org/10.1634/theoncologist.2013-0120
Laird, Barry J. ; McMillan, Donald C. ; Fayers, Peter ; Fearon, Kenneth ; Kaasa, Stein ; Fallon, Marie T. ; Klepstad, Pål. / The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer. In: Oncologist. 2013 ; Vol. 18, No. 9. pp. 1050-1055.
@article{8de9d6f3249540a29c9d23ba04b07696,
title = "The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer",
abstract = "Introduction. Inflammation has been identified as a hallmark of cancer and may be necessary for tumorgenesis and maintenance of the cancer state. Inflammation-related symptoms are common in those with cancer; however, little is known about the relationship between symptoms and systemic inflammation in cancer. The aim of the present study was to examine the relationship between symptoms and systemic inflammation in a large cohort of patients with advanced cancer. Methods. Data from an international cohort of patients with advanced cancer were analyzed. Symptoms and patient-related outcomes were recorded using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core Questionnaire. Systemic inflammation was assessed using C-reactive protein levels. The relationship between these symptoms and systemic inflammation was examined using Spearman rank correlation (ρ) and the Mann-Whitney U test. Results. Data were available for 1,466 patients across eight European countries; 1,215 patients (83{\%}) had metastatic disease at study entry. The median survival was 3.8 months (interquartile range [IQR] 1.3-12.2 months). The following were associated with increased levels of inflammation: performance status (p=.179), survival (p=.347), pain (p=.154), anorexia (p=.206), cognitive dysfunction (p=.137), dyspnea (p.150), fatigue (p=.197), physical dysfunction (p=.207), role dysfunction (p=.176), social dysfunction (p=.132), and poor quality of life (p=.178). All were statistically significant at p<.001. Conclusion. The results show that the majority of cancer symptoms are associated with inflammation. The strength of the potential relationship between systemic inflammation and common cancer symptoms should be examined further within the context of an anti-inflammatory intervention trial.",
keywords = "Cancer, Inflammation, Symptoms",
author = "Laird, {Barry J.} and McMillan, {Donald C.} and Peter Fayers and Kenneth Fearon and Stein Kaasa and Fallon, {Marie T.} and P{\aa}l Klepstad",
note = "The biobank data collection was funded by the Norwegian Research Council and the European Union’s 6th Framework (Contract 037777). Marie T. Fallon and P{\aa}l Klepstad served as joint senior authors on this paper",
year = "2013",
month = "9",
doi = "10.1634/theoncologist.2013-0120",
language = "English",
volume = "18",
pages = "1050--1055",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer

AU - Laird, Barry J.

AU - McMillan, Donald C.

AU - Fayers, Peter

AU - Fearon, Kenneth

AU - Kaasa, Stein

AU - Fallon, Marie T.

AU - Klepstad, Pål

N1 - The biobank data collection was funded by the Norwegian Research Council and the European Union’s 6th Framework (Contract 037777). Marie T. Fallon and Pål Klepstad served as joint senior authors on this paper

PY - 2013/9

Y1 - 2013/9

N2 - Introduction. Inflammation has been identified as a hallmark of cancer and may be necessary for tumorgenesis and maintenance of the cancer state. Inflammation-related symptoms are common in those with cancer; however, little is known about the relationship between symptoms and systemic inflammation in cancer. The aim of the present study was to examine the relationship between symptoms and systemic inflammation in a large cohort of patients with advanced cancer. Methods. Data from an international cohort of patients with advanced cancer were analyzed. Symptoms and patient-related outcomes were recorded using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core Questionnaire. Systemic inflammation was assessed using C-reactive protein levels. The relationship between these symptoms and systemic inflammation was examined using Spearman rank correlation (ρ) and the Mann-Whitney U test. Results. Data were available for 1,466 patients across eight European countries; 1,215 patients (83%) had metastatic disease at study entry. The median survival was 3.8 months (interquartile range [IQR] 1.3-12.2 months). The following were associated with increased levels of inflammation: performance status (p=.179), survival (p=.347), pain (p=.154), anorexia (p=.206), cognitive dysfunction (p=.137), dyspnea (p.150), fatigue (p=.197), physical dysfunction (p=.207), role dysfunction (p=.176), social dysfunction (p=.132), and poor quality of life (p=.178). All were statistically significant at p<.001. Conclusion. The results show that the majority of cancer symptoms are associated with inflammation. The strength of the potential relationship between systemic inflammation and common cancer symptoms should be examined further within the context of an anti-inflammatory intervention trial.

AB - Introduction. Inflammation has been identified as a hallmark of cancer and may be necessary for tumorgenesis and maintenance of the cancer state. Inflammation-related symptoms are common in those with cancer; however, little is known about the relationship between symptoms and systemic inflammation in cancer. The aim of the present study was to examine the relationship between symptoms and systemic inflammation in a large cohort of patients with advanced cancer. Methods. Data from an international cohort of patients with advanced cancer were analyzed. Symptoms and patient-related outcomes were recorded using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core Questionnaire. Systemic inflammation was assessed using C-reactive protein levels. The relationship between these symptoms and systemic inflammation was examined using Spearman rank correlation (ρ) and the Mann-Whitney U test. Results. Data were available for 1,466 patients across eight European countries; 1,215 patients (83%) had metastatic disease at study entry. The median survival was 3.8 months (interquartile range [IQR] 1.3-12.2 months). The following were associated with increased levels of inflammation: performance status (p=.179), survival (p=.347), pain (p=.154), anorexia (p=.206), cognitive dysfunction (p=.137), dyspnea (p.150), fatigue (p=.197), physical dysfunction (p=.207), role dysfunction (p=.176), social dysfunction (p=.132), and poor quality of life (p=.178). All were statistically significant at p<.001. Conclusion. The results show that the majority of cancer symptoms are associated with inflammation. The strength of the potential relationship between systemic inflammation and common cancer symptoms should be examined further within the context of an anti-inflammatory intervention trial.

KW - Cancer

KW - Inflammation

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=84884556878&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2013-0120

DO - 10.1634/theoncologist.2013-0120

M3 - Article

C2 - 23966223

AN - SCOPUS:84884556878

VL - 18

SP - 1050

EP - 1055

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 9

ER -